St. Louis-based Stereotaxis, Inc. is at the forefront of designing, manufacturing, and distributing robotic systems, instruments, and information systems for interventional laboratories worldwide. The company's robotic magnetic navigation (RMN) systems, including the Genesis RMN and Niobe systems, offer physicians an image-guided delivery mechanism of catheters and guidewires through the blood vessels and heart chambers for complex interventional procedures. Stereotaxis also provides Odyssey, a real-time information solution for procedure management, control, and sharing across networks, along with the Stereotaxis Imaging Model S X-ray system. Additionally, the company offers disposables such as the QuikCAS automated catheter advancement disposables and various catheters. Stereotaxis products are marketed via a direct sales force, distributors, and sales agents. The company recently announced its strategic partnership with Osypka AG to develop a magnetic ablation catheter using Stereotaxis' robotic technology. Founded in 1990, Stereotaxis is headquartered in St. Louis, Missouri, and has a well-established international presence.
Stereotaxis's ticker is STXS
The company's shares trade on the OTC stock exchange
They are based in Saint Louis, Missouri
There are 51-200 employees working at Stereotaxis
It is stereotaxis.com
Stereotaxis is in the Healthcare sector
Stereotaxis is in the Medical Appliances & Equipment industry
The following five companies are Stereotaxis's industry peers: